Absence of ADA results in accumulation of these toxic metabolites, causing a subtype of severe combined immunodeficiency (SCID) characterized by severe lymphocytopenia affecting T- and B-lymphocytes and NK cells and accounts for approximately 10–15% of all SCID cases, although the proportion is higher in some ethnic groups [1–3]. The gene discussed is ADA; the disease is severe combined immunodeficiency.